HOBIT (Traumatic Brain Injury) - Clinical Trial
Email to Participate
erica.walker@duke.edu
What is the Purpose of this Study?
Treatment
We are doing this study to learn if hyperbaric oxygen therapy (HBOT) is helpful to people with traumatic brain injury.
What is the Condition Being Studied?
Objective
Traumatic Brain Injury (TBI)
Who Can Participate in the Study?
Key Eligibility
- Men and Women 16-65 years old
- Have a traumatic brain injury
- Able to complete their first hyperbaric treatment within 8-14 hours of being admitted to the hospital
Age Group
Adults, Children
What is Involved?
Description
If you choose to join this study you will:
- Be randomized (like drawing numbers out of a hat) to be 1 one of 8 groups
-- 6 groups will receive hyperbaric oxygen therapy (HBOT)
-- 1 group will receive a high dose of oxygen that is not pressurized
-- 1 group will get standard care
- All groups will complete a follow-up visit (on the phone or in-person) at month 3 and 6 after treatment
Study Details
Full Title
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial: A Multicenter, Randomized, Prospective Phase II Adaptive Clinical Trial Evaluating the Most Effective Hyperbaric Oxygen Treatment Paradigm for Severe Traumatic Brain Injury
Principal Investigator
Neurotologist
Protocol Number
IRB:
PRO00093798
NCT:
NCT02407028
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Email erica.walker@duke.edu